A four-marker panel of HE4, Tie-2, OPG, and HGF including age as a cofactor was also identified to distinguish benign conditions, including CP and IPMN, from healthy controls. This evidence concerns the gene WFDC2 and pancreatic intraductal papillary-mucinous neoplasm.